Medical device maker Viant is exploring strategic options including a potential sale that could value it at $2 billion to $3 billion and perhaps more, according to people familiar with the matter.
The company, backed by health-care focused private equity firm
Viant is expected to draw takeover interest ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.